MedPath

A clinical trial to study the effect of Kutajavaleha in Grahani Roga

Phase 2
Conditions
Health Condition 1: K582- Mixed irritable bowel syndrome
Registration Number
CTRI/2019/01/017277
Lead Sponsor
Central Council for Research in Ayurvedic Sciences New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Known cases of Grahani roga (diagnostic criteria as per classical Ayurvedic Parameters)

2. Patient willing to give written informed consent for participation in the study.

Exclusion Criteria

1.Patients with history of Inflammatory bowel diseases (IBD), Abdominal Koch,Gluten Intolerance.

2.Patients with history of Chronic amoebiasis.

3.Known cases of Diabetes mellitus.

4.Patients with poorly controlled Hypertension ( >160/100 mmHg).

5.Patients who have history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.

6.Symptomatic patients with clinical evidence of Heart failure.

7.Known cases of malignancy.

8.Patients with concurrent serious hepatic disorders (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease (COPD).

9.Women who are planning for conception / pregnant or lactating.

10.H/o hypersensitivity to any of the trial drugs or their ingredients

11. Patients who have completed participation in any other clinical trial during the past three months.

12.Any other condition which the Investigator thinks may jeopardize the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath